ghk-cu peptide clinical research (Copper Peptide) 50mg & 100mg GHK-Cu – 50mg – Peptidic.
Description
Gastrointestinal Distress: Acute systemic loads exceeding 10 mg frequently trigger nausea, severe cramping, and gastrointestinal rejection
No licensed provider can prescribe those, and a program that would is a program to avoid
Such molecules may be appropriate for use at the first indication of mild cognitive impairment, and perhaps prophylactically in those individuals who are most likely to develop dementia due to genetic, health, behavioral and life-style predisposing factors
Typically 18-24 months from the time of order.
But most reactions are mild to moderate, typically resolving within 24-48 hours
